ArticleTranslational lung cancer research2018
The continued EGFR-TKI with cytotoxic chemotherapy at progression-poison or medicine?
Shin-Kyo Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it